Factors Affecting Low Hematopoietic Cell Transplantation Rates in TP53-Mutated MDS/AML and Predictors of Overall Survival
Jennifer Marvin‐Peek(The University of Texas MD Anderson Cancer Center), Michael Byrne(Vanderbilt University Medical Center), Reena Jayani(Vanderbilt University Medical Center), Adetola A. Kassim(Vanderbilt University), Michael R. Savona(Vanderbilt University), Sanjay Mohan(Breast Cancer Research Foundation), Brian G. Engelhardt(Vanderbilt University Medical Center), Bhagirathbhai Dholaria(Vanderbilt University Medical Center), Tae Kon Kim(Vanderbilt University), Emily F. Mason(Vanderbilt University Medical Center), Bipin N. Savani(Vanderbilt University Medical Center), Heidi Chen(Vanderbilt University Medical Center), Stephen A. Strickland(Vanderbilt University)
Cited by 0
Related Papers
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Acute Myeloid Leukemia, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2017|655
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes
|Nature Medicine|2020|633